Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model
Open Access
- 20 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Fluids and Barriers of the CNS
- Vol. 9 (1), 2
- https://doi.org/10.1186/2045-8118-9-2
Abstract
Background: Convection-enhanced delivery (CED), a direct method for drug delivery to the brain through intraparenchymal microcatheters, is a promising strategy for intracerebral pharmacological therapy. By establishing a pressure gradient at the tip of the catheter, drugs can be delivered in uniform concentration throughout a large volume of interstitial fluid. However, the variables affecting perivascular distribution of drugs delivered by CED are not fully understood. The aim of this study was to determine whether the perivascular distribution of solutes delivered by CED into the striatum of rats is affected by the molecular weight of the infused agent, by co-infusion of vasodilator, alteration of infusion rates or use of a ramping regime. We also wanted to make a preliminary comparison of the distribution of solutes with that of nanoparticles. Methods: We analysed the perivascular distribution of 4, 10, 20, 70, 150 kDa fluorescein-labelled dextran and fluorescent nanoparticles at 10 min and 3 h following CED into rat striatum. We investigated the effect of local vasodilatation, slow infusion rates and ramping on the perivascular distribution of solutes. Co-localisation with perivascular basement membranes and vascular endothelial cells was identified by immunohistochemistry. The uptake of infusates by perivascular macrophages was quantified using stereological methods. Results: Widespread perivascular distribution and macrophage uptake of fluorescein-labelled dextran was visible 10 min after cessation of CED irrespective of molecular weight. However, a significantly higher proportion of perivascular macrophages had taken up 4, 10 and 20 kDa fluorescein-labelled dextran than 150 kDa dextran (p < 0.05, ANOVA). Co-infusion with vasodilator, slow infusion rates and use of a ramping regime did not alter the perivascular distribution. CED of fluorescent nanoparticles indicated that particles co-localise with perivascular basement membranes throughout the striatum but, unlike soluble dextrans, are not taken up by perivascular macrophages after 3 h. Conclusions: This study suggests that widespread perivascular distribution and interaction with perivascular macrophages is likely to be an inevitable consequence of CED of solutes. The potential consequences of perivascular distribution of therapeutic agents, and in particular cytotoxic chemotherapies, delivered by CED must be carefully considered to ensure safe and effective translation to clinical trials.Keywords
This publication has 38 references indexed in Scilit:
- Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and NeurotoxicityInternational Journal of Environmental Research and Public Health, 2011
- An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced deliveryJournal of Neuroscience Methods, 2011
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyNeuro-Oncology, 2010
- Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumorsDrug Delivery and Translational Research, 2010
- Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNSJournal of Neuroimmunology, 2010
- Dual Roles for Perivascular Macrophages in Immune-to-Brain SignalingNeuron, 2010
- Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathyProceedings of the National Academy of Sciences of the United States of America, 2009
- Diffusion in Brain Extracellular SpacePhysiological Reviews, 2008
- The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the BrainMolecular Therapy, 2006
- Mechanisms to explain the reverse perivascular transport of solutes out of the brainJournal of Theoretical Biology, 2006